Kraig Biocraft Laboratories Inc (KBLB)

[kblbpatience]

I've come on here and spouted numbers like $20 a share in 10 years and a buck sometime in 2011, and have never supported my thinking. I will try to give you all a little view of where I'm coming from, at least long term.

The key word from the post I'm responding to is "testing". Gen2 and Gen3 will take extensive, and EXPENSIVE, testing. This will totally be the key to how much us REALLY LONG holders will ultimately make on this investment. The agreements Mr. Thompson puts together for this purpose will be all important. He either puts together favorable deals where the partner puts up a huge chunk for these purposes, or Mr. Thompson starts taking some of those 9.5 billion shares off the shelf to pay for it. The dilution that is done in 2012 and 2013 for testing expenses will determine the ultimate price we will get per share. We'll either split the big money up a billion ways, or split it up 5 billion ways. As I've said before, this long term investment comes down to your confidence in the CEO, and how he handles this part of the program. People looking for $2 per share will have to wait until 2013 to see how the financing for the all important testing of Gen2 and Gen3 is done. If done economically by Mr. Thompson, $2 should be there during that year, and if those tests go according to plan, $20 in 10 years has to be considered a slam dunk.

As long as dilution doesn't take place for basic operating expenses, we should be fine, and there hasn't been any indication anything like that will happen, at least short term. The dilution will take place during the Gen2 and Gen3 testing phases, and then to what degree is all important.